Is the rate of virological failure to cART continuing to decline in recent calendar years?
•Notwithstanding modern HAART therapies HIV + subjects continue to fail.•In the ICONA cohort the rate of VF increased with higher numbers of previous VFs.•The rate of VF had been lower in recent years, e.g. 2014–2017 vs 2006–2009.•Several factors were associated to a lower risk of VF.•These are Ital...
Gespeichert in:
Veröffentlicht in: | Journal of clinical virology 2019-07, Vol.116, p.23-28 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 28 |
---|---|
container_issue | |
container_start_page | 23 |
container_title | Journal of clinical virology |
container_volume | 116 |
creator | Rusconi, Stefano Santoro, Maria M Gianotti, Nicola Antinori, Andrea Bonora, Stefano Cingolani, Antonella Ceccherini Silberstein, Francesca Tavelli, Alessandro d’Arminio Monforte, Antonella Cozzi-Lepri, Alessandro |
description | •Notwithstanding modern HAART therapies HIV + subjects continue to fail.•In the ICONA cohort the rate of VF increased with higher numbers of previous VFs.•The rate of VF had been lower in recent years, e.g. 2014–2017 vs 2006–2009.•Several factors were associated to a lower risk of VF.•These are Italian origin, longer virological suppression, and university education.
Despite the high rate of virological success of combined antiretroviral therapy (cART), HIV infected individuals continue to fail. In this contest, it is unclear whether having previously experienced virological failure (VF) of cART remains an important predictor of future risk of VF in people receiving cART in modern times. We investigated the rate of VF and factors potentially associated with this event in 9220 HIV-1 infected patients enrolled in the Icona Cohort who showed a stable viral suppression on modern cART regimens after January 1, 2006.
We investigated two main exposure factors: current calendar period (2006–2009; 2010–2013; 2014–2017) and number of VFs (0; 1–3; >3) prior to baseline. Relative rates of VF were estimated from fitting a Poisson regression model.
Seven-hundred-seventy-nine patients experienced VF over follow-up for an overall rate of 2.08 per 100 person years of follow-up (PYFU, 95%CI: 1.93–2.22). The rate of VF increased with higher numbers of previous VFs: patients with >3 previous VFs had a rate of 4.87 (4.10–5.78), 2.75-fold higher than that observed in patients without any previous VF (p |
doi_str_mv | 10.1016/j.jcv.2019.04.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2231846449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1386653219300976</els_id><sourcerecordid>2231846449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-63a55f73d2d549c4be6ab979342d2e82b151bb2aeedc93de39072fd28b1d3f663</originalsourceid><addsrcrecordid>eNp9kE1LHTEUhkNRql79Ad1Ilm5mmu-Z4KKItFa4UBDduAmZ5IzNZW5ik5kL_ntzubbLrs7h8LwvnAehL5S0lFD1ddNu3K5lhOqWiJYQ_Qmd0r7jjdSqO6o771WjJGcn6KyUDSFUctF9Rieckk5K0Z-i5_uC59-As50BpxHvQk5TegnOTni0YVoy4Dlhd_PwiF2Kc4hLiC_7kwc3hQg4RJzBQZxxzUD0NuM3sLl8O0fHo50KXHzMFXr68f3x9mez_nV3f3uzbhzXam4Ut1KOHffMS6GdGEDZQXeaC-YZ9Gygkg4DswDeae6Ba9Kx0bN-oJ6PSvEVujr0vub0Z4Eym20oDqbJRkhLMYxx2gslhK4oPaAup1IyjOY1h63Nb4YSs1dqNqYqNXulhghTldbM5Uf9MmzB_0v8dViB6wMA9cldgGyKCxAd-FDFzMan8J_6dzFXhuk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2231846449</pqid></control><display><type>article</type><title>Is the rate of virological failure to cART continuing to decline in recent calendar years?</title><source>Access via ScienceDirect (Elsevier)</source><creator>Rusconi, Stefano ; Santoro, Maria M ; Gianotti, Nicola ; Antinori, Andrea ; Bonora, Stefano ; Cingolani, Antonella ; Ceccherini Silberstein, Francesca ; Tavelli, Alessandro ; d’Arminio Monforte, Antonella ; Cozzi-Lepri, Alessandro</creator><creatorcontrib>Rusconi, Stefano ; Santoro, Maria M ; Gianotti, Nicola ; Antinori, Andrea ; Bonora, Stefano ; Cingolani, Antonella ; Ceccherini Silberstein, Francesca ; Tavelli, Alessandro ; d’Arminio Monforte, Antonella ; Cozzi-Lepri, Alessandro ; for the Icona Foundation Study Group ; Icona Foundation Study Group</creatorcontrib><description>•Notwithstanding modern HAART therapies HIV + subjects continue to fail.•In the ICONA cohort the rate of VF increased with higher numbers of previous VFs.•The rate of VF had been lower in recent years, e.g. 2014–2017 vs 2006–2009.•Several factors were associated to a lower risk of VF.•These are Italian origin, longer virological suppression, and university education.
Despite the high rate of virological success of combined antiretroviral therapy (cART), HIV infected individuals continue to fail. In this contest, it is unclear whether having previously experienced virological failure (VF) of cART remains an important predictor of future risk of VF in people receiving cART in modern times. We investigated the rate of VF and factors potentially associated with this event in 9220 HIV-1 infected patients enrolled in the Icona Cohort who showed a stable viral suppression on modern cART regimens after January 1, 2006.
We investigated two main exposure factors: current calendar period (2006–2009; 2010–2013; 2014–2017) and number of VFs (0; 1–3; >3) prior to baseline. Relative rates of VF were estimated from fitting a Poisson regression model.
Seven-hundred-seventy-nine patients experienced VF over follow-up for an overall rate of 2.08 per 100 person years of follow-up (PYFU, 95%CI: 1.93–2.22). The rate of VF increased with higher numbers of previous VFs: patients with >3 previous VFs had a rate of 4.87 (4.10–5.78), 2.75-fold higher than that observed in patients without any previous VF (p < 0.001). The rate of VF was lower in recent years: 3.81 (3.36, 4.32) in 2006–2009; 1.36 (1.20–1.53) in 2014–2017 (p < 0.001). Other factors independently associated with lower risk of VF were Italian origin, longer history of virological suppression, and university education level.
In HIV-infected patients virologically suppressed after January 2006, the rate of VF continues to show a decline even in the most recent years. Previous VFs should be carefully considered.</description><identifier>ISSN: 1386-6532</identifier><identifier>EISSN: 1873-5967</identifier><identifier>DOI: 10.1016/j.jcv.2019.04.009</identifier><identifier>PMID: 31075548</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><ispartof>Journal of clinical virology, 2019-07, Vol.116, p.23-28</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-63a55f73d2d549c4be6ab979342d2e82b151bb2aeedc93de39072fd28b1d3f663</citedby><cites>FETCH-LOGICAL-c396t-63a55f73d2d549c4be6ab979342d2e82b151bb2aeedc93de39072fd28b1d3f663</cites><orcidid>0000-0002-0375-9990</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jcv.2019.04.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31075548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rusconi, Stefano</creatorcontrib><creatorcontrib>Santoro, Maria M</creatorcontrib><creatorcontrib>Gianotti, Nicola</creatorcontrib><creatorcontrib>Antinori, Andrea</creatorcontrib><creatorcontrib>Bonora, Stefano</creatorcontrib><creatorcontrib>Cingolani, Antonella</creatorcontrib><creatorcontrib>Ceccherini Silberstein, Francesca</creatorcontrib><creatorcontrib>Tavelli, Alessandro</creatorcontrib><creatorcontrib>d’Arminio Monforte, Antonella</creatorcontrib><creatorcontrib>Cozzi-Lepri, Alessandro</creatorcontrib><creatorcontrib>for the Icona Foundation Study Group</creatorcontrib><creatorcontrib>Icona Foundation Study Group</creatorcontrib><title>Is the rate of virological failure to cART continuing to decline in recent calendar years?</title><title>Journal of clinical virology</title><addtitle>J Clin Virol</addtitle><description>•Notwithstanding modern HAART therapies HIV + subjects continue to fail.•In the ICONA cohort the rate of VF increased with higher numbers of previous VFs.•The rate of VF had been lower in recent years, e.g. 2014–2017 vs 2006–2009.•Several factors were associated to a lower risk of VF.•These are Italian origin, longer virological suppression, and university education.
Despite the high rate of virological success of combined antiretroviral therapy (cART), HIV infected individuals continue to fail. In this contest, it is unclear whether having previously experienced virological failure (VF) of cART remains an important predictor of future risk of VF in people receiving cART in modern times. We investigated the rate of VF and factors potentially associated with this event in 9220 HIV-1 infected patients enrolled in the Icona Cohort who showed a stable viral suppression on modern cART regimens after January 1, 2006.
We investigated two main exposure factors: current calendar period (2006–2009; 2010–2013; 2014–2017) and number of VFs (0; 1–3; >3) prior to baseline. Relative rates of VF were estimated from fitting a Poisson regression model.
Seven-hundred-seventy-nine patients experienced VF over follow-up for an overall rate of 2.08 per 100 person years of follow-up (PYFU, 95%CI: 1.93–2.22). The rate of VF increased with higher numbers of previous VFs: patients with >3 previous VFs had a rate of 4.87 (4.10–5.78), 2.75-fold higher than that observed in patients without any previous VF (p < 0.001). The rate of VF was lower in recent years: 3.81 (3.36, 4.32) in 2006–2009; 1.36 (1.20–1.53) in 2014–2017 (p < 0.001). Other factors independently associated with lower risk of VF were Italian origin, longer history of virological suppression, and university education level.
In HIV-infected patients virologically suppressed after January 2006, the rate of VF continues to show a decline even in the most recent years. Previous VFs should be carefully considered.</description><issn>1386-6532</issn><issn>1873-5967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LHTEUhkNRql79Ad1Ilm5mmu-Z4KKItFa4UBDduAmZ5IzNZW5ik5kL_ntzubbLrs7h8LwvnAehL5S0lFD1ddNu3K5lhOqWiJYQ_Qmd0r7jjdSqO6o771WjJGcn6KyUDSFUctF9Rieckk5K0Z-i5_uC59-As50BpxHvQk5TegnOTni0YVoy4Dlhd_PwiF2Kc4hLiC_7kwc3hQg4RJzBQZxxzUD0NuM3sLl8O0fHo50KXHzMFXr68f3x9mez_nV3f3uzbhzXam4Ut1KOHffMS6GdGEDZQXeaC-YZ9Gygkg4DswDeae6Ba9Kx0bN-oJ6PSvEVujr0vub0Z4Eym20oDqbJRkhLMYxx2gslhK4oPaAup1IyjOY1h63Nb4YSs1dqNqYqNXulhghTldbM5Uf9MmzB_0v8dViB6wMA9cldgGyKCxAd-FDFzMan8J_6dzFXhuk</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Rusconi, Stefano</creator><creator>Santoro, Maria M</creator><creator>Gianotti, Nicola</creator><creator>Antinori, Andrea</creator><creator>Bonora, Stefano</creator><creator>Cingolani, Antonella</creator><creator>Ceccherini Silberstein, Francesca</creator><creator>Tavelli, Alessandro</creator><creator>d’Arminio Monforte, Antonella</creator><creator>Cozzi-Lepri, Alessandro</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0375-9990</orcidid></search><sort><creationdate>201907</creationdate><title>Is the rate of virological failure to cART continuing to decline in recent calendar years?</title><author>Rusconi, Stefano ; Santoro, Maria M ; Gianotti, Nicola ; Antinori, Andrea ; Bonora, Stefano ; Cingolani, Antonella ; Ceccherini Silberstein, Francesca ; Tavelli, Alessandro ; d’Arminio Monforte, Antonella ; Cozzi-Lepri, Alessandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-63a55f73d2d549c4be6ab979342d2e82b151bb2aeedc93de39072fd28b1d3f663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rusconi, Stefano</creatorcontrib><creatorcontrib>Santoro, Maria M</creatorcontrib><creatorcontrib>Gianotti, Nicola</creatorcontrib><creatorcontrib>Antinori, Andrea</creatorcontrib><creatorcontrib>Bonora, Stefano</creatorcontrib><creatorcontrib>Cingolani, Antonella</creatorcontrib><creatorcontrib>Ceccherini Silberstein, Francesca</creatorcontrib><creatorcontrib>Tavelli, Alessandro</creatorcontrib><creatorcontrib>d’Arminio Monforte, Antonella</creatorcontrib><creatorcontrib>Cozzi-Lepri, Alessandro</creatorcontrib><creatorcontrib>for the Icona Foundation Study Group</creatorcontrib><creatorcontrib>Icona Foundation Study Group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rusconi, Stefano</au><au>Santoro, Maria M</au><au>Gianotti, Nicola</au><au>Antinori, Andrea</au><au>Bonora, Stefano</au><au>Cingolani, Antonella</au><au>Ceccherini Silberstein, Francesca</au><au>Tavelli, Alessandro</au><au>d’Arminio Monforte, Antonella</au><au>Cozzi-Lepri, Alessandro</au><aucorp>for the Icona Foundation Study Group</aucorp><aucorp>Icona Foundation Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the rate of virological failure to cART continuing to decline in recent calendar years?</atitle><jtitle>Journal of clinical virology</jtitle><addtitle>J Clin Virol</addtitle><date>2019-07</date><risdate>2019</risdate><volume>116</volume><spage>23</spage><epage>28</epage><pages>23-28</pages><issn>1386-6532</issn><eissn>1873-5967</eissn><abstract>•Notwithstanding modern HAART therapies HIV + subjects continue to fail.•In the ICONA cohort the rate of VF increased with higher numbers of previous VFs.•The rate of VF had been lower in recent years, e.g. 2014–2017 vs 2006–2009.•Several factors were associated to a lower risk of VF.•These are Italian origin, longer virological suppression, and university education.
Despite the high rate of virological success of combined antiretroviral therapy (cART), HIV infected individuals continue to fail. In this contest, it is unclear whether having previously experienced virological failure (VF) of cART remains an important predictor of future risk of VF in people receiving cART in modern times. We investigated the rate of VF and factors potentially associated with this event in 9220 HIV-1 infected patients enrolled in the Icona Cohort who showed a stable viral suppression on modern cART regimens after January 1, 2006.
We investigated two main exposure factors: current calendar period (2006–2009; 2010–2013; 2014–2017) and number of VFs (0; 1–3; >3) prior to baseline. Relative rates of VF were estimated from fitting a Poisson regression model.
Seven-hundred-seventy-nine patients experienced VF over follow-up for an overall rate of 2.08 per 100 person years of follow-up (PYFU, 95%CI: 1.93–2.22). The rate of VF increased with higher numbers of previous VFs: patients with >3 previous VFs had a rate of 4.87 (4.10–5.78), 2.75-fold higher than that observed in patients without any previous VF (p < 0.001). The rate of VF was lower in recent years: 3.81 (3.36, 4.32) in 2006–2009; 1.36 (1.20–1.53) in 2014–2017 (p < 0.001). Other factors independently associated with lower risk of VF were Italian origin, longer history of virological suppression, and university education level.
In HIV-infected patients virologically suppressed after January 2006, the rate of VF continues to show a decline even in the most recent years. Previous VFs should be carefully considered.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31075548</pmid><doi>10.1016/j.jcv.2019.04.009</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0375-9990</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1386-6532 |
ispartof | Journal of clinical virology, 2019-07, Vol.116, p.23-28 |
issn | 1386-6532 1873-5967 |
language | eng |
recordid | cdi_proquest_miscellaneous_2231846449 |
source | Access via ScienceDirect (Elsevier) |
title | Is the rate of virological failure to cART continuing to decline in recent calendar years? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T14%3A35%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20rate%20of%20virological%20failure%20to%20cART%20continuing%20to%20decline%20in%20recent%20calendar%20years?&rft.jtitle=Journal%20of%20clinical%20virology&rft.au=Rusconi,%20Stefano&rft.aucorp=for%20the%20Icona%20Foundation%20Study%20Group&rft.date=2019-07&rft.volume=116&rft.spage=23&rft.epage=28&rft.pages=23-28&rft.issn=1386-6532&rft.eissn=1873-5967&rft_id=info:doi/10.1016/j.jcv.2019.04.009&rft_dat=%3Cproquest_cross%3E2231846449%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2231846449&rft_id=info:pmid/31075548&rft_els_id=S1386653219300976&rfr_iscdi=true |